Consistent with this finding, the repression of Mi-2β expression correlated with a substantial survival benefit in melanoma patients with high CD8+ T-cell infiltration (p < 0.05), but not in melanomas with low CD8+ T-cell infiltration (Supplementary Fig. 1e). The gene discussed is CHD4; the disease is melanoma.